What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Endocrinology
His primary areas of investigation include Internal medicine, Endocrinology, Psychiatry, Schizophrenia and Dopamine.
As part of his studies on Internal medicine, he frequently links adjacent subjects like Depression.
His Endocrinology study combines topics in areas such as Receptor, Fenfluramine, Serotonin and Prefrontal cortex.
His Psychiatry study incorporates themes from Placebo and Randomized controlled trial.
The Schizophrenia study combines topics in areas such as Clinical Global Impression, Psychosis, Pharmacology and Clinical psychology.
His Schizoaffective disorder research is multidisciplinary, relying on both Clozapine and Olanzapine.
His most cited work include:
- Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. (976 citations)
- Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. (827 citations)
- The psychotomimetic effects of intravenous Delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis (725 citations)
What are the main themes of his work throughout his whole career to date?
Thomas B. Cooper spends much of his time researching Internal medicine, Endocrinology, Anesthesia, Pharmacology and Psychiatry.
Thomas B. Cooper has included themes like Schizophrenia and Depression in his Internal medicine study.
His Schizophrenia study combines topics from a wide range of disciplines, such as Haloperidol and Psychosis.
His Endocrinology research is multidisciplinary, incorporating elements of Receptor, Homovanillic acid and Serotonin.
His Anesthesia research focuses on subjects like Placebo, which are linked to Randomized controlled trial.
His study on Psychiatry is mostly dedicated to connecting different topics, such as Clinical psychology.
He most often published in these fields:
- Internal medicine (72.37%)
- Endocrinology (60.53%)
- Anesthesia (23.68%)
What were the highlights of his more recent work (between 2005-2021)?
- Internal medicine (72.37%)
- Endocrinology (60.53%)
- Psychiatry (20.61%)
In recent papers he was focusing on the following fields of study:
Thomas B. Cooper mainly investigates Internal medicine, Endocrinology, Psychiatry, Major depressive disorder and Endocannabinoid system.
As part of the same scientific family, Thomas B. Cooper usually focuses on Internal medicine, concentrating on Depression and intersecting with Fenfluramine.
His Endocrinology study integrates concerns from other disciplines, such as Homovanillic acid, Cannabinoid and Neuroscience.
His work deals with themes such as Placebo and Clinical psychology, which intersect with Psychiatry.
His Endocannabinoid system research incorporates themes from Striatum, Anandamide, Fatty acid amide hydrolase, Cannabinoid receptor and Hippocampus.
His research in the fields of Clozapine overlaps with other disciplines such as In patient.
Between 2005 and 2021, his most popular works were:
- Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. (389 citations)
- Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD. (332 citations)
- Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers with ADHD. (332 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Endocrinology
- Dopamine
His primary scientific interests are in Internal medicine, Endocrinology, Cannabinoid, Pharmacology and Endocannabinoid system.
Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Major depressive disorder.
His research on Endocrinology frequently connects to adjacent areas such as Ketamine.
His study in Cannabinoid is interdisciplinary in nature, drawing from both Psychotomimetic and Cannabis.
He focuses mostly in the field of Psychotomimetic, narrowing it down to matters related to Psychopharmacology and, in some cases, Schizophrenia.
Thomas B. Cooper interconnects Receptor and Amphetamine in the investigation of issues within Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
